Fed Chair presented his quarterly testimony to the House yesterday and will testify to the Senate today. The market reaction was minimal as much of his speech was a repeat of last week’s and .

As is typical at these quarterly presentations, he will present identical testimony to both houses of Congress. Accordingly, we are likely to learn very little as Powell testifies to the Senate today.

Here are some key takeaways:

, we noted that the market rallied on Iran’s muted response to the U.S. attack on its nuclear facilities. Notably, that rally yesterday broke the market above the “bullish wedge” pattern that was developing, giving the bulls room to push stock prices higher yesterday.

At the open, stocks gapped higher and rallied into initial resistance from the December highs. However, there is a lot of momentum and short-covering in the market as we wind up the quarter, so a test of all-time highs is quite likely. Importantly, after a successful test of support and a breakout above the recent consolidation range, there is little to stop the market’s advance.

Any weakness in the market through the month-end should be bought. July tends to be one of the strongest months of the year, so increases in exposure will likely do well over the next 30 days. With earnings season set to begin after the July 4th holiday, there is little reason to be overly cautious with allocations or exposures.

The top SimpleVisor graphic below breaks down the absolute and relative scores for the top 10 stocks within the materials sector ETF (). As shown, Corteva (NYSE:) and Newmont (NYSE:) are relatively overbought compared to the market. Conversely, the majority of the remaining material stocks are languishing in comparison.

Newmont, a gold miner, is benefiting from the strong upward trend in gold. Corteva (CTVA) is a lesser-known company. Let’s use SimpleVisor to learn more about the company.

The following screenshot from SimpleVisor is a description of what CTVA does:

Corteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability.

The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.

The second screenshot below shows that CTVA, up 31% year-to-date, has been grossly outperforming the in 2025. The third graphic offers caution. It shows that EPS has been relatively flat for the last ten years. Furthermore, the stock price, at $74.44, is trading at over 2x its fair value of $30.22.

Not shown, but revenue also exhibits minimal growth. The last graphic combines two SimpleVisor pages. The top one compares its valuations with those of its top competitors. The second provides a broad technical summary. Not surprisingly, it has a strong buy rating, but as we surmised by its relative score, it is very overbought. CTVA is trading above all its key moving averages. Traders can utilize these levels and pivot points to help identify potential areas of support.